Chronic, recurrent Lymphocytic Leukemia Completed Phase 2 Trials for Cyclophosphamide (DB00531)

Also known as: Recurrent Chronic Lymphocytic Leukemia

IndicationStatusPhase
DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00723099Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerTreatment
NCT01008462Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaTreatment